首页> 外文期刊>Transactions of the Royal Society of Tropical Medicine and Hygiene >Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi.
【24h】

Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi.

机译:马拉维国家结核病控制计划中涂片阴性和涂片阳性肺结核患者的治疗结果。

获取原文
获取原文并翻译 | 示例
       

摘要

National tuberculosis control programmes (NTPs) in sub-Saharan Africa do not routinely record or report treatment outcome data on smear-negative pulmonary tuberculosis (PTB) patients. Twelve-month treatment outcome on patients with smear-negative PTB registered in all district and mission hospitals in Malawi during the year 1995 was collected, and was compared with 8-month treatment outcome in smear-positive PTB patients registered during the same period. Of 4240 patients with smear-negative PTB, 35% completed treatment, 25% died, 9% defaulted and 7% were transferred to another district with no treatment outcome results available. In 24% of patients treatment cards were lost and treatment outcome was unknown. These results were significantly inferior to those obtained in 4003 patients with smear-positive PTB in whom 72% completed treatment, 20% died, 4% defaulted, 2% were transferred and 1% had positive smears at the end of treatment. These differences between patients with smear-negative and smear-positive PTB were similar when analysed by sex and by most age-groups. Higher mortality rates in patients with smear-negative PTB are probably attributable to advanced HIV-related immunosuppression, and higher default and treatment unknown rates probably reflect the lack of attention paid by TB programme staff to this group of patients. As a result of this country-wide study the Malawi NTP has started to record routinely the treatment outcomes of smear-negative TB patients and has set treatment completion targets of 50% or higher for this group of patients.
机译:撒哈拉以南非洲国家结核病控制计划(NTP)不会常规记录或报告涂片阴性肺结核(PTB)患者的治疗结果数据。收集了1995年在马拉维所有地区医院和宣教医院登记的涂片阴性PTB患者的12个月治疗结果,并将其与同期注册的涂片阳性PTB患者的8个月治疗结果进行了比较。在4240名涂片阴性PTB患者中,35%完成治疗,25%死亡,9%违约和7%被转移到另一个地区,没有可用的治疗结果。 24%的患者失去了治疗卡,治疗结果未知。这些结果显着低于在4003例涂阳的PTB患者中获得的结果,其中72%完成治疗,20%死亡,4%违约,2%被转移以及1%在治疗结束时涂片阳性。当按性别和大多数年龄组进行分析时,涂片阴性和涂片阳性PTB患者之间的这些差异相似。涂片阴性PTB患者的较高死亡率可能归因于与HIV相关的晚期免疫抑制,较高的默认率和未知治疗率可能反映了TB计划人员对此人群缺乏关注。这项全国性研究的结果是,马拉维NTP已开始常规记录涂片阴性结核病患者的治疗结果,并将该组患者的治疗完成目标设定为50%或更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号